Gene Therapy May Improve Survival of Patients with Recurrent Ovarian Cancer

Use of gene therapy to deliver a protein that suppresses the development of female reproductive organs may improve the survival of patients with ovarian cancer that has recurred after chemotherapy, which happens 70 percent of the time and is invariably fatal. In their report, a Massachusetts General Hospital research team describes how a single injection of a modified version of Mullerian Inhibiting Substance, a protein critical to sexual development, carried on a commonly used viral vector sup...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news